Literature DB >> 26262800

Screening for Chronic Kidney Disease.

Milda R Saunders1, Adam Cifu2, Monica Vela2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26262800      PMCID： PMC4813784          DOI： 10.1001/jama.2015.9425

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  Chronic kidney disease controversy: how expanding definitions are unnecessarily labelling many people as diseased.

Authors:  Ray Moynihan; Richard Glassock; Jenny Doust
Journal:  BMJ       Date:  2013-07-29

2.  Awareness of chronic kidney disease among patients and providers.

Authors:  Laura C Plantinga; Delphine S Tuot; Neil R Powe
Journal:  Adv Chronic Kidney Dis       Date:  2010-05       Impact factor: 3.620

3.  Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study.

Authors:  Sabin Shurraw; Brenda Hemmelgarn; Meng Lin; Sumit R Majumdar; Scott Klarenbach; Braden Manns; Aminu Bello; Matthew James; Tanvir Chowdhury Turin; Marcello Tonelli
Journal:  Arch Intern Med       Date:  2011-11-28

4.  Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Lori D Bash; Elizabeth Selvin; Michael Steffes; Josef Coresh; Brad C Astor
Journal:  Arch Intern Med       Date:  2008-12-08

Review 5.  Current issues in measurement and reporting of urinary albumin excretion.

Authors:  W Greg Miller; David E Bruns; Glen L Hortin; Sverre Sandberg; Kristin M Aakre; Matthew J McQueen; Yoshihisa Itoh; John C Lieske; David W Seccombe; Graham Jones; David M Bunk; Gary C Curhan; Andrew S Narva
Journal:  Clin Chem       Date:  2008-11-21       Impact factor: 8.327

Review 6.  KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.

Authors:  Lesley A Inker; Brad C Astor; Chester H Fox; Tamara Isakova; James P Lash; Carmen A Peralta; Manjula Kurella Tamura; Harold I Feldman
Journal:  Am J Kidney Dis       Date:  2014-03-16       Impact factor: 8.860

7.  Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: A clinical practice guideline from the American College of Physicians.

Authors:  Amir Qaseem; Robert H Hopkins; Donna E Sweet; Melissa Starkey; Paul Shekelle
Journal:  Ann Intern Med       Date:  2013-12-17       Impact factor: 25.391
  7 in total
  11 in total

1.  Racial and Ethnic Disparities in Diagnosis of Chronic Medical Conditions in the USA.

Authors:  Eun Ji Kim; Taekyu Kim; Joseph Conigliaro; Jane M Liebschutz; Michael K Paasche-Orlow; Amresh D Hanchate
Journal:  J Gen Intern Med       Date:  2018-05-07       Impact factor: 5.128

2.  End-Stage Renal Disease Outcomes among the Kaiser Permanente Southern California Creatinine Safety Program (Creatinine SureNet): Opportunities to Reflect and Improve.

Authors:  John J Sim; Michael Batech; Kim N Danforth; Mark P Rutkowski; Steven J Jacobsen; Michael H Kanter
Journal:  Perm J       Date:  2017

3.  Machine learning distilled metabolite biomarkers for early stage renal injury.

Authors:  Yan Guo; Hui Yu; Danqian Chen; Ying-Yong Zhao
Journal:  Metabolomics       Date:  2019-12-05       Impact factor: 4.290

4.  GAG and collagen II attenuate glucocorticoid-induced osteoporosis by regulating NF-κB and MAPK signaling.

Authors:  Han Zhu; Meng Wang; Chengjun Zhao; Ruosong Li; Juan Yang; Guangchang Pei; Ting Ye; Xuezhi Zuo; Liu Liu; Octavia Ls Chong Lee Shin; Fengming Zhu; Jie Sun; Huzi Xu; Zhi Zhao; Chujin Cao; Yuxi Wang; Qian Yang; Gang Xu; Rui Zeng; Ying Yao
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

5.  Guidelines adherence in the prevention and management of chronic kidney disease in patients with diabetes mellitus on the background of recent European recommendations - a registry-based analysis.

Authors:  Peter Bramlage; Stefanie Lanzinger; Sascha R Tittel; Eva Hess; Simon Fahrner; Christoph H J Heyer; Mathias Friebe; Ivo Buschmann; Thomas Danne; Jochen Seufert; Reinhard W Holl
Journal:  BMC Nephrol       Date:  2021-05-19       Impact factor: 2.388

6.  Community Pharmacy-Based eGFR Screening for Early Detection of CKD in High Risk Patients.

Authors:  John Papastergiou; Michelle Donnelly; Wilson Li; Robert D Sindelar; Bart van den Bemt
Journal:  Can J Kidney Health Dis       Date:  2020-05-18

7.  Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists.

Authors:  Nicola Schieda; Jason I Blaichman; Andreu F Costa; Rafael Glikstein; Casey Hurrell; Matthew James; Pejman Jabehdar Maralani; Wael Shabana; An Tang; Anne Tsampalieros; Christian B van der Pol; Swapnil Hiremath
Journal:  Can J Kidney Health Dis       Date:  2018-06-12

8.  Renal function deterioration in adult patients with type-2 diabetes.

Authors:  Peter Bramlage; Stefanie Lanzinger; Eva Hess; Simon Fahrner; Christoph H J Heyer; Mathias Friebe; Ivo Buschmann; Thomas Danne; Reinhard W Holl; Jochen Seufert
Journal:  BMC Nephrol       Date:  2020-07-29       Impact factor: 2.388

9.  Early detection of chronic kidney disease in low-income and middle-income countries: development and validation of a point-of-care screening strategy for India.

Authors:  Christina Bradshaw; Dimple Kondal; Maria E Montez-Rath; Jialin Han; Yuanchao Zheng; Roopa Shivashankar; Ruby Gupta; Nikhil Srinivasapura Venkateshmurthy; Prashant Jarhyan; Sailesh Mohan; Viswanathan Mohan; Mohammed K Ali; Shivani Patel; K M Venkat Narayan; Nikhil Tandon; Dorairaj Prabhakaran; Shuchi Anand
Journal:  BMJ Glob Health       Date:  2019-09-03

10.  Association of retinal venular tortuosity with impaired renal function in the Northern Ireland Cohort for the Longitudinal Study of Ageing.

Authors:  R A O'Neill; A P Maxwell; F Kee; I Young; B McGuinness; R E Hogg; McKay Gj
Journal:  BMC Nephrol       Date:  2020-09-03       Impact factor: 2.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.